TCS Biosciences EU

Mechelen ·KBO/BCE: BE 1002.442.342

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	8.0%	27.4%	better than 26% of 963 sector peers
Net result	€42k	€24k	better than 58% of 963 sector peers
Equity	€52k	€172k	better than 33% of 963 sector peers
Gross operating margin	€51k	€174k	better than 31% of 961 sector peers
Total assets	€652k	€859k	better than 42% of 963 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€652k
Current assets	29/58	€652k
Amounts receivable within one year	40/41	€576k
Cash & bank	54/58	€77k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€652k
Equity	10/15	€52k
Contributions / capital	10/11	€10k
Reserves	13	€42k
Amounts payable	17/49	€600k
Amounts payable within one year	42/48	€600k
Trade debts payable within one year	44	€550k
Income statement
Gross operating margin	9900	€51k
Operating result	9901	€50k
Financial income	75	€2k
Financial charges	65	€197
Result before taxes	9903	€52k
Income taxes	67/77	€10k
Net result for the period	9904	€42k
Result to be appropriated	9905	€42k

Summary